Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.
Funding Hazel Technologies, a US-based anti-food waste technology developer, said it has completed documentation for a $70m series C round featuring Asahi Kasei Ventures, the investment arm of chemicals producer Asahi Kasei. The round was co-led by Pontifax AgTech and Temasek, and included S2G Ventures, Pangaea Ventures, Rhapsody Venture Partners, Jordan Park Group and Jeremy…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.